Procollagen propeptides: Serum markers for atrial fibrosis?

Clinical Research in Cardiology

Volumn 101, Issue 8, 2012, Pages 655-661

  Neuberger, Hans Ruprecht ^a   Cacciatore, Angela ^a   Reil, Jan Christian ^a   Gräber, Stefan ^b   Schäfers, Hans Joachim ^a   Ukena, Christian ^a   Böhm, Michael ^a   Mewis, Christian ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Atrial arrhythmias; Atrial fibrosis; Biomarkers; Cardiac surgery; Collagen; Procollagen propeptides

Indexed keywords

AMINO TERMINAL PROPEPTIDE OF TYPE I PROCOLLAGEN; AMINO TERMINAL PROPEPTIDE OF TYPE III PROCOLLAGEN; CARBOXY TERMINAL PROPEPTIDE OF TYPE I PROCOLLAGEN; COLLAGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; FIBROSING ALVEOLITIS; FIBROSIS; GENETIC HETEROGENEITY; HEART ATRIUM; HEART ATRIUM FIBROSIS; HEART SURGERY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PROSPECTIVE STUDY; SINUS RHYTHM;

AGED; BIOLOGICAL MARKERS; FEMALE; FIBROSIS; HEART ATRIA; HUMANS; MALE; PEPTIDE FRAGMENTS; PROCOLLAGEN; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84865731360     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-012-0440-6     Document Type: Article

References (15)

1. Burstein B, Nattel S (2008) Atrial fibrosis: Mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 51:802-809
2. Lopez B, Gonzalez A, Querejeta R, Diez J (2005) The use of collagen-derived serum peptides for the clinical assessment of hypertensive heart disease. J Hypertens 23:1445-1451
3. Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L (1993) Radioimmunoassay for the pyridinoline cross-linked carboxyterminal telopeptide of type I collagen: A new serum marker of bone collagen degradation. Clin Chem 39:635-640
4. Querejeta R, Varo N, Lopez B, Larman M, Artinano E, Etayo JC, Ubago JLM, Gutierrez-Stampa M, Emparanza JI, Gil MJ, Monreal I, Mindan JP, Diez J (2000) Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. Circulation 101:1729-1735
5. Uusimaa P, Risteli J, Niemela M, Lumme J, Ikaheimo M, Jounela A, Peuhkurinen K (1997) Collagen scar formation after acute myocardial infarction: Relationships to infarct size, left ventricular function, and coronary artery patency. Circulation 96:2565-2572
6. Kallergis EM, Manios EG, Kanoupakis EM, Mavrakis HE, Arfanakis DA, Maliaraki NE, Lathourakis CE, Chlouverakis GI, Vardas PE (2008) Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: Biochemical assessment of collagen type-I turnover. J Am Coll Cardiol 52:211-215
7. Tziakas DN, Chalikias GK, Papanas N, Stakos DA, Chatzikyriakou SV, Maltezos E (2007) Circulating levels of collagen type I degradation marker depend on the type of atrial fibrillation. Europace 9:589-596
8. Sezai A, Hata M, Niino T, Kasamaki Y, Nakai T, Hirayama A, Minami K (2009) Study of the factors related to atrial fibrillation after coronary artery bypass grafting: A search for a marker to predict the occurrence of atrial fibrillation before surgical intervention. J Thorac Cardiovasc Surg 137:895-900
9. Timonen P, Magga J, Risteli J, Punnonen K, Vanninen E, Turpeinen A, Tuomainen P, Kuusisto J, Vuolteenaho O, Peuhkurinen K (2008) Cytokines, interstitial collagen and ventricular remodelling in dilated cardiomyopathy. Int J Cardiol 124:293-300
10. Kawamura M, Ito H, Onuki T, Miyoshi F, Watanabe N, Asano T, Tanno K, Kobayashi Y (2010) Candesartan decreases type III procollagen-N-peptide levels and inflammatory marker levels and maintains sinus rhythm in patients with atrial fibrillation. J Cardiovasc Pharmacol 55:511-517
11. Neuberger HR, Schotten U, Blaauw Y, Vollmann D, Eijsbouts S, van Hunnik A, Allessie M (2006) Chronic atrial dilation, electrical remodeling, and atrial fibrillation in the goat. J Am Coll Cardiol 47:644-653
12. Li D, Fareh S, Leung TK, Nattel S (1999) Promotion of atrial fibrillation by heart failure in dogs: Atrial remodeling of a different sort. Circulation 100:87-95
13. Neuberger HR, Mewis C, Van Veldhuisen DJ, Schotten U, Van Gelder IC, Allessie MA, Böhm M (2007) Management of atrial fibrillation in patients with heart failure. Eur Heart J 28:2568-2577
14. Klappacher G, Franzen P, Haab D, Mehrabi M, Binder M, Plesch K, Pacher R, Grimm M, Pribill I, Eichler HG (1995) Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis. Am J Cardiol 75:913-918
15. Behnes M, Hoffmann U, Lang S, Weiss C, Ahmad-Nejad P, Neumaier M, Borggrefe M, Brueckmann M (2011) Transforming growth factor beta 1 (TGF-beta 1) in atrial fibrillation and acute congestive heart failure. Clin Res Cardiol 100:335-342